lncRNAs: potential therapeutic targets and biomarkers for pancreatic cancer?
Sign Up to like & getrecommendations! Published in 2021 at "Expert Opinion on Therapeutic Targets"
DOI: 10.1080/14728222.2021.1938541
Abstract: Pancreatic ductal adenocarcinoma (PDAC) is a leading cause of cancer-related deaths with limited therapeutic opportunities [1]. Recently, molecular analysis uncovered interand intratumoral heterogeneity, signaling pathways commonly upregulated in PDAC and revealed strategies for patient stratification… read more here.
Keywords: lncrnas potential; therapeutic targets; targets biomarkers; pancreatic cancer ... See more keywords